Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
MONIREA
1 other identifier
interventional
60
1 country
2
Brief Summary
In this clinical study, the investigators will compare vital parameters measurements obtained using continuous data from reference monitors and continuous wireless MultiSense® monitoring patch in 60 post-ICU (Intensive Care Unit) patients and over 7 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2020
CompletedFirst Posted
Study publicly available on registry
December 10, 2020
CompletedStudy Start
First participant enrolled
September 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2025
CompletedMay 1, 2025
April 1, 2025
3.5 years
December 7, 2020
April 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Determination of the quality of measurements of clinical signs provided by MultiSense® strip in comparison to measurements made with conventional medical devices in the hospital setting, in terms of accuracy.
Accuracy is defined as an average measurement variation less than 3.5 percent or 5 percent of the mean value, depending on the variable with respect to the reference standard.
from patch placement to hospital discharge, assessed up to 7 days
Determination of the quality of measurements of clinical signs provided by MultiSense® strip in comparison to measurements made with conventional medical devices in the hospital setting, in terms of connectivity.
Connectivity is defined as a time-wise ratio of missing versus total signal less than 20 percent.
from patch placement to hospital discharge, assessed up to 7 days
Determination of the quality of measurements of clinical signs provided by MultiSense® strip in comparison to measurements made with conventional medical devices in the hospital setting, in terms of generation of artifactual data.
The generation of artefact data is defined as a percentage of outlier data less than 10 percent.
from patch placement to hospital discharge, assessed up to 7 days
Determination of the quality of measurements of clinical signs provided by MultiSense® strip in comparison to measurements made with conventional medical devices in the hospital setting, in terms of stability of data transmission.
Data transmission stability is defined as a data transmission rate equal to or greater than 80 percent.
from patch placement to hospital discharge, assessed up to 7 days
Secondary Outcomes (7)
Usability of a data acquisition patch by health care providers (HCPs) in the setting of post-ICU, rehabilitation unit assessed via a questionnaire.
At hospital discharge, up to 7 days after the patch placement
User experience of post-ICU rehabilitation patients with the continuous use of the adhesive data acquisition patch during remote monitoring assessed via a patient's final questionnaire.
At hospital discharge, up to 7 days after the patch placement
Assess patients' tolerability to prolonged use of an adhesive patch during remote monitoring.
From patch placement to its removal (up to 7 days)
Assess the correlation between body temperature and skin temperature
From patch placement to its removal (up to 7 days)
Assess the ability of the patch to detect and signal the clinically confirmed excursions of heart rate (high and low) outside predefined thresholds
From patch placement to its removal (up to 7 days)
- +2 more secondary outcomes
Study Arms (1)
Remote Automated Monitoring System
EXPERIMENTALMultiSense® strip will be attached on patient's thorax. The monitoring will last between 5 and 7 days during the post-ICU hospitalization, at rest and during rehabilitation exercises.
Interventions
The patient will be monitored with conventional monitoring devices as well as the MultiSense patch.
Eligibility Criteria
You may qualify if:
- Man or woman over 18 years old.
- Patient previously cared in an ICU for severe COVID-19 pneumonia, COVID-related condition or similar neurological compromise necessitating post-ICU rehabilitation
- Negative respiratory SARS-CoV-2 (Severe Acute Respiratory Syndrome-Corona Virus-2) samples
- Patient admitted in a post-ICU rehabilitation unit with an expected length of stay \> 5 days
- Patient able to receive and understand information related to the study and give written informed consent.
- OR If the patient is not capable, presence of a next of kin able to receive and understand information related to the study and give written informed consent for the patient
- Patient authorizing the treatment of their personal data collected during the study (box checked in the consent form)
- Patient affiliated to the French social security system.
You may not qualify if:
- Patient with a skin disease that would preclude the use of an adhesive.
- Patient with an implantable device such as a pacemaker
- Pregnant or lactating patient.
- Patient under guardianship or trusteeship.
- Patient under the protection of justice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IHU Strasbourglead
- Rhythm Diagnostic Systemscollaborator
Study Sites (2)
Anesthesia Department, Central Hospital
Nancy, 54000, France
Anesthesia, Critical Care & Perioperative Medicine, Hautepierre
Strasbourg, 67000, France
Related Publications (1)
Pamuk K, Turan N. The effect of light on sleep quality and physiological parameters in patients in the intensive care unit. Appl Nurs Res. 2022 Aug;66:151607. doi: 10.1016/j.apnr.2022.151607. Epub 2022 Jun 26.
PMID: 35840273DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Julien POTTECHER, MD, PhD
Anesthesia, Critical Care & Perioperative Medicine, Hautepierre, Strasbourg, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2020
First Posted
December 10, 2020
Study Start
September 2, 2021
Primary Completion
March 2, 2025
Study Completion
March 2, 2025
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share